erythromycin has been researched along with Hepatocellular Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lamers, CB; van Dissel, JT; van Hoek, B; Veenendaal, RA; Vermeij, CG | 1 |
1 review(s) available for erythromycin and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Campylobacter jejuni peritonitis in a patient with liver cirrhosis.
Topics: Anti-Bacterial Agents; Bacteremia; Campylobacter Infections; Campylobacter jejuni; Carcinoma, Hepatocellular; Erythromycin; Humans; Liver Cirrhosis, Alcoholic; Liver Neoplasms; Male; Middle Aged; Peritonitis | 1996 |